Safety of physical examination alone for managing well-appearing neonates ≥35 weeks gestation at risk for early-onset sepsis

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 28, Issue 10, 2015, Pages 1123-1127

  Berardi, Alberto ^a   Fornaciari, Sara ^a   Rossi, Cecilia ^b   Patianna, Viviana ^a   Bacchi Reggiani, Maria Letizia ^c   Ferrari, Filippo ^a   Neri, Isabella ^a   Ferrari, Fabrizio ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Azienda Ospedaliera Santa Maria Nuova   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Group B Streptococcus; intrapartum antibiotic prophylaxis; management; neonatal sepsis; prevention

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLOOD CELL COUNT; BLOOD CULTURE; C REACTIVE PROTEIN TEST; CLINICAL ARTICLE; COHORT ANALYSIS; DRUG USE; EARLY DIAGNOSIS; ESCHERICHIA COLI; GESTATIONAL AGE; GRUNTING; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; IMMUNOLOGICAL PROCEDURES; INFECTION RISK; INTERMETHOD COMPARISON; LABORATORY TEST; LENGTH OF STAY; LETHARGY; LISTERIA MONOCYTOGENES; MEDICAL RECORD REVIEW; NEWBORN; NEWBORN SEPSIS; PATIENT SAFETY; PHYSICAL EXAMINATION; PREDICTOR VARIABLE; PRENATAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SOUND; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; TACHYPNEA; WELL APPEARING AT RISK NEWBORN; FEMALE; MALE; PROCEDURES; SEPSIS;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; COHORT STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; LENGTH OF STAY; MALE; PHYSICAL EXAMINATION; RETROSPECTIVE STUDIES; RISK FACTORS; SEPSIS;

EID: 84940648659     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2014.946499     Document Type: Article

References (19)

1. Palazzi D, Klein J, Baker C. Bacterial sepsis and meningitis. In: Remington J, Klein J, Wilson C, Baker C, eds. Infectious diseases of the fetus and newborn infant. 6th ed. Philadelphia: Elsevier Saunders; 2006:247-95.
2. Verani JR, McGee L, Schrag SJ. Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centres for Disease Control and Prevention (CDC). Prevention of perinatal group B Streptococcal disease-revised guidelines from CDC, 2010. MMWR Recomm Rep 2010;59:1-36.
3. Weston EJ, Pondo T, Lewis MM, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J 2011;30:937-41.
4. Stoll BJ, Hansen NI, Sánchez PJ, et al. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics 2011;127:817-26.
5. National Institute for Health and Clinical Excellence. Antibiotics for early-onset neonatal infection: antibiotics for the prevention and treatment of early-onset neonatal infection. (CG102). London: NICE; 2012. Available from: http://guidance.nice.org.uk/CG149/ Guidance/pdf/English [last accessed 13 Sep 2013].
6. Mukhopadhyay S, Puopolo KM. Risk assessment in neonatal early onset sepsis. Semin Perinatol 2012;36:408-15.
7. Hsu KK, Pelton SI, Shapiro DS. Detection of group B Streptococcal bacteremia in simulated intrapartum antimicrobial prophylaxis. Diagn Microbiol Infect Dis 2003;45:23-7.
8. Ottolini MC, Lundgren K, Mirkinson LJ, et al. Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn. Pediatr Infect Dis J 2003;22: 430-4.
9. Newman TB, Puopolo KM, Draper D, Escobar GJ. Interpreting complete blood counts soon after birth in newborns at risk for sepsis. Pediatrics 2010;126:903-9.
10. Hofer N, Zacharias E, Müller W, Resch B. An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks. Neonatology 2012;102:25-36.
11. Escobar GJ, Li DK, Armstrong MA, et al. Neonatal sepsis workups in infants 2000 grams at birth: a population-based study. Pediatrics 2000;106:256-63.
12. Brady MT, Polin RA. Prevention and management of infants with suspected or proven neonatal sepsis. Pediatrics 2013;132: 166-8.
13. Berardi A, Lugli L, Rossi C, et al.; GBS Prevention Working Group, Emilia-Romagna. Impact of perinatal practices for early-onset group-B streptococcal disease prevention. Pediatr Infect Dis J 2013;32:e265-71.
14. Berardi A, Lugli L, Baronciani D, et al.; GBS Prevention Working Group of Emilia-Romagna. Group B Streptococcus early-onset disease in Emilia-Romagna: review after introduction of a screening-based approach. Pediatr Infect Dis J 2010;29: 115-22.
15. Bedford Russell AR, Murch SH. Could peripartum antibiotics have delayed health consequences for the infant? BJOG 2006;113: 758-65.
16. Moore MR, Schrag SJ, Schuchat A. Effects of intrapartum antimicrobialprophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis 2003;3:201-13.
17. Alm B, Erdes L, Möllborg P, et al. Neonatal antibiotic treatment is a risk factor for early wheezing. Pediatrics 2008;121:697-702.
18. Cantoni L, Ronfani L, Da Riol R, Demarini S. Physical examination instead of laboratory tests for most infants born to mothers colonized with group B Streptococcus: support for the Centers for Disease Control and Prevention's 2010 Recommendations. J Pediatr 2013;163:568-73.
19. Berardi A, Lugli L, Baronciani D, et al.; GBS Prevention Working Group of Emilia-Romagna. Group B Streptococcal infections in a Northern region of Italy. Pediatrics 2007;120:e487-93.